+30.4%
GSK vs ACM
-45.8%
+76.2%
-18.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | ACM | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.9% | -0.4% | -1.6% | -1.9% |
| 7D | -1.8% | -3.7% | +1.9% | -1.4% |
| 30D | -2.2% | -11.1% | +8.9% | -0.8% |
| 3M | -1.8% | -8.0% | +6.2% | -1.1% |
| 6M | -10.6% | -29.7% | +19.0% | -7.3% |
| YTD | +4.4% | -29.4% | +33.8% | +7.5% |
| 1Y | +30.4% | -46.4% | +76.8% | +41.2% |
| All | +30.4% | -45.8% | +76.2% | +41.2% |
Cumulative growth
Daily Returns
Daily percentage return beside ACM.
Daily Out/Under-Performance
Portfolio return minus ACM return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ACM return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded ACM wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling